Patents Assigned to Zebra Pharmaceuticals
  • Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
    Patent number: 6004990
    Abstract: Novel meta substituted arylakylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission, such as depression and obesity.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: December 21, 1999
    Assignee: Zebra Pharmaceuticals
    Inventors: David R. Elmaleh, Alan J. Fischman